Parabilis Medicines is a clinical-stage biopharmaceutical company creating groundbreaking therapies by targeting previously undruggable biological pathways. They have developed Helicon™ peptides, a novel class of alpha-helical peptides, which are engineered to modulate intracellular proteins effectively. With a focus on diseases driven by the Wnt/β-catenin pathway, their lead candidate, zolucatetide, represents a unique solution for patients facing serious health challenges.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching
Want job alerts that match your preferences?
Set up job preferences →